FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas

Author:

Milton Christopher I.1ORCID,Selfe Joanna1,Aladowicz Ewa1,Man Stella Y. K.1,Bernauer Carolina1,Missiaglia Edoardo1,Walters Zoë S.1ORCID,Gatz Susanne A.1,Kelsey Anna2,Generali Melanie1ORCID,Box Gary3,Valenti Melanie3,Haven‐Brandon Alexis3,Galiwango David4,Hayes Angela4,Clarke Matthew5,Izquierdo Elisa5ORCID,Gonzalez De Castro David6,Raynaud Florence I.4,Kirkin Vladimir3,Shipley Janet M.1ORCID

Affiliation:

1. Sarcoma Molecular Pathology Team Divisions of Molecular Pathology and Cancer Therapeutics The Institute of Cancer Research London UK

2. Department of Paediatric Histopathology Manchester University NHS Foundation Trust Royal Manchester Children’s Hospital UK

3. Cancer Pharmacology and Stress Response Team Division of Cancer Therapeutics The Institute of Cancer Research London UK

4. Drug Metabolism and Pharmacokinetics Team Division of Cancer Therapeutics The Institute of Cancer Research London UK

5. Glioma Team Division of Molecular Pathology The Institute of Cancer Research London UK

6. Molecular Haematology Division of Molecular Pathology The Institute of Cancer Research London UK

Funder

Cancer Research UK

Children's Cancer and Leukaemia Group

CHILDREN with CANCER UK

Chris Lucas Trust

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3